Skip to content

Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company on $2.1 Million Private Placement for Nanox Imaging PLC

Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger

CollabRx, Inc.

Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction

Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants

Sichenzia Ross Friedman Ference LLP Advises Zenovia Digital Exchange Corp. on $5 Million Private Placement Transaction

Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering

Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.

Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering

Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation

Cell Source

SMTP, Inc.

Be Active Holdings

Valor Gold Corp

Pegasi Energy Resources

Yappn

BitCoin Shop Inc.